ACRX - AcelRx Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue7,99517,35719,2635,217
Cost of Revenue30,06833,71724,25824,520
Gross Profit-22,073-16,360-4,995-19,303
Operating Expenses
Research Development----
Selling General and Administrative16,60915,59714,20318,346
Non Recurring----
Others----
Total Operating Expenses46,67749,31438,46142,866
Operating Income or Loss-38,682-31,957-19,198-37,649
Income from Continuing Operations
Total Other Income/Expenses Net-13,527-11,234-4,4414,296
Earnings Before Interest and Taxes-38,682-31,957-19,198-37,649
Interest Expense-14,037-12,152-5,405-2,639
Income Before Tax-52,209-43,191-23,639-33,353
Income Tax Expense-701-34760-
Minority Interest----
Net Income From Continuing Ops-51,508-43,157-24,399-33,353
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-51,508-43,157-24,399-33,353
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-51,508-43,157-24,399-33,353